Effective March 1 - Online Orders Changing
As you may be aware, Virusys Corporation is now officially part of the LGC Clinical Diagnostics (CDx) business unit. Virusys’ monoclonal antibody technologies and virology expertise are highly complementary to LGC Clinical Diagnostics’ existing antigen and immunoassay product portfolios and will enable us to provide customers with antibody technologies to accelerate their infectious disease research programs, including influenza A and B, Herpes Simplex viruses, and Varicella Zoster, which can cause diseases like Chickenpox and Shingles.
How does this affect me?
We are currently in the process of transitioning all customers into our ERP system. Learn more by clicking here.
LGC acquires Virusys Corporation
CUSTOMER NOTICE:
We're pleased to announce that Virusys Corporation has been acquired by LGC, a leading global Life Sciences tools company.
This will complement and strengthen the portfolio of antibodies and antigens for infectious disease available for customers.
To find out more about this exciting news, click here https://www.lgcgroup.com/newsroom-and-blog/news-and-blog/lgc-acquires-virusys-corporation/
We will be in touch with our customers directly and if you have any questions in the meantime, please contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
